L-canavanine improves organ function and tissue adenosine triphosphate levels in rodent endotoxemia

American Journal of Respiratory and Critical Care Medicine

Volumn 155, Issue 5, 1997, Pages 1643-1648

  Liaudet, Lucas ^a   Fishman, Daniel ^a   Markert, Michèle ^a   Perret, Claude ^a   Feihl, François ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CANAVANINE; ENDOTOXIN; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENDOTOXEMIA; HYPOTENSION; KIDNEY FAILURE; LIVER FAILURE; MALE; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; RAT; SEPTIC SHOCK;

EID: 0030989272     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.155.5.9154870     Document Type: Article

References (43)

1. Szabo, C. 1995. Alterations in nitric oxide production in various forms of circulatory shock. New Horiz. 3:2-32.
2. Thiemermann, C., and J. Vane. 1990. Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur. J. Pharmacol. 182:591-595.
3. Petros, A., G. Lamb, A. Leone, S. Moncada, D. Bennett, and P. Vallance. 1994. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc. Res. 28:34-39.
4. w-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J. Exp. Med. 176:1175-1182.
5. Spain, D. A., M. A. Wilson, and R. N. Garison. 1994. Nitric oxide synthase inhibition exacerbates sepsis-induced renal hypoperfusion. Surgery 116:322-331.
6. Wright, C. E., D. D. Rees, and S. Moncada. 1992. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc. Res. 26: 48-57.
7. Statman. R., W. Cheng, J. N. Cunningham, J. L. Henderson, P. Damiani, A. Siconolfi, D. Rogers, and J. H. Horovitz. 1994. Nitric oxide inhibition in the treatment of the sepsis syndrome is detrimental to tissue oxygenation. J. Surg. Res. 57:93-98.
8. Boughton-Smith, N. K., I. R. Hutcheson, A. M. Deakin, B. J. R. Whittle, and S. Moncada. 1990. Protective effect of S-nitroso-N-acetyl-peniciltamine in endotoxin-induced acute intestinal damage in the rat. Eur. J. Pharmacol. 191:485-488.
9. Harbrecht, B. G., T. R. Billiar, J. Stadler, A. J. Demetris, J. B. Ochoa, R. D. Curran, and R. L. Simmons. 1992. Nitric oxide synthesis serves to reduce hepatic damage during acute murine endotoxemia. Crit. Care Med. 20:1568-1574.
10. Schultz, P., and L. Raij. 1992. Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J. Clin. Invest. 90: 1718-1725.
11. Szabo, C., G. J. Southan, and C. Thiemermann. 1994. Beneficial effects and improved survival in rodent models of septic shock with S-methyl-isothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc. Natl. Acad. Sci. U.S.A. 91:12472-12476.
12. Aranow, J. S., J. Zhuang, H. Wang, V. Larkin, M. Smith, and M. P. Fink. 1996. A selective inhibitor of inducible nitric oxide synthase prolongs survival in a rat model of bacterial peritonitis: comparison with two nonselective strategies. Shock 5:116-121.
13. Wu, C. C., S. J. Chen, C. Szabo, C. Thiemermann, and J. R. Vane. 1995. Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock. Br. J. Pharmacol. 114:1666-1672.
14. Liaudet, L., F. Feihl, A. Rosselet, M. Markert, and C. Perret. 1996. Beneficial effects of L-canavanine, a selective inhibitor of inducible nitric oxide synthase, during rodent endotoxemia. Clin. Sci. 90:369-377.
15. Gutierrez, G., N. Lund, and C. W. Bryan-Brown. 1989. Cellular oxygen utilization during multiple organ failure. Crit. Care Clin. 5:271-287.
16. Markert, M., A. Ney, and C. Bachmann. 1995. Nitrate determination in biological fluids adapted on a centrifugal analyzer. Schweiz. Med. Wochenschr. Suppl. 125(Suppl. 69):285.
17. Jaworek, D., J. Welsch, I. Trautschold, W. Lamprecht, G. Schweitzer, K. Wulff, and W. Döppen. Adenosine-5′-triphosphate, UV method with phosphoglycerate kinase. In H. V. Bergmeyer, editor. Methods of Enzymatic Analysis, 3rd ed. VCH Verlagsgesellschaft, Weinheim. 340-346.
18. Hochberg, Y. 1988. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 75:800-803.
19. Knowles, R. G., M. Merrett, M. Salter, and S. Moncada. 1990. Differential induction of brain, lung and liver nitric oxide synthase by endotoxin in the rat. Biochem. J. 270:833-836.
20. Umans, J. G., and R. W. Samsel. 1992. L-Canavanine selectively augments contraction in aortas from endotoxemic rats. Eur. J. Pharmacol. 210:343-346.
21. Wu, C. C., H. Ruetten, and C. Thiemermann. 1996. Comparison of the effects of aminoguanidine and Nw-nitro-L-arginine methyl ester on the multiple organ dysfunction caused by endotoxaemia in the rat. Eur. J. Pharmacol. 300:99-104.
22. Bogle, R. G., R. J. MacAllister, G. S. J. Whitley, and P. Vallance. 1995. Induction of NG-monomethyl-L-arginine uptake: a mechanism for differential inhibition of NO synthases? Am. J. Physiol. 269:C750-C756.
23. Baydoun, A. R., and G. E. Mann. 1994. Selective targeting of nitric oxide synthase inhibitors to system y+ in activated macrophages. Biochem. Biophys. Res. Commun. 200:726-731.
24. Peterson, D. A., D. C. Peterson, S. Archer, and E. K. Weir. 1992. The non specificity of specific nitric oxide synthase inhibitors. Biochem. Biophys. Res. Commun. 187:797-801.
25. Teale, D. M., and A. M. Atkinson. 1994. L-Canavanine restores blood pressure in a rat model of endotoxic shock. Eur. J. Pharmacol. 271:87-92.
26. Cai, M., A. Sakamoto, and R. Ogawa. 1996. Inhibition of nitric oxide formation with L-canavanine attenuates endotoxin-induced vascular hyporeactivity in the rat. Eur. J. Pharmacol. 295:215-220.
27. Fishman, D., L. Liaudet, R. Lazor, F. Feihl, and C. Perret. 1996. L-Canavanine, a selective inhibitor of inducible nitric oxide synthase, improves venous return in endotoxemic rats. Crit. Care Med. (In press)
28. Hotchkiss, R. S., and I. E. Karl. 1992. Reevaluation of the role of cellular hypoxia and bioenergetic failure in sepsis. J.A.M.A. 267:1503-1510.
29. Kopprasch, S., U. Hörkner, H. Orlik, C. Kemmer, and D. W. Scheuch. 1989. Energy state, glycolytic intermediates and mitochondrial function in the liver during reversible and irreversible endotoxin shock. Biomed. Biochim. Acta 48:653-659.
30. Tanaka, J., T. Sato, Y. Kamiyama, R. T. Jones, R. A. Cowley, and B. F. Trump. 1982. Bacteremic shock: aspects of high-energy metabolism of rat liver following living Escherichia coli injection. J. Surg. Res. 33:49-57.
31. Van Lambalgen, A. A., A. A. Van Kraats, M. F. Mulder, T. Teerlink, and G. C. Van den Bos. 1994. High-energy phosphates in heart, liver, kidney, and skeletal muscle of endotoxemic rats. Am. J. Physiol. 266: H1581-H1587.
32. VanderMeer, T. J., H. Wang, and M. P. Fink. 1995. Endotoxemia causes ileal mucosal acidosis in the absence of mucosal hypoxia in a normodynamic porcine model of septic shock. Crit. Care Med. 23:1217-1226.
33. Astiz, M., E. C. Rackow, M. H. Weil, and W. Schumer. 1988. Early impairment of oxidative metabolism and energy production in severe sepsis. Circ. Shock 26:311-320.
34. Biber, B., C. F. Schaefer, M. J. Smolik, M. R. Lerner, D. J. Brackett, M. F. Wilson, and L. Fagraeus. 1988. Improved techniques for cardiovascular monitoring in rats as applied during endotoxemia. Am. J. Physiol. 254:H181-H186.
35. Geng, Y. J., G. K. Hansson, and E. Holme. 1992. Interferon-γ and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells. Circ. Res. 71:1268-1276.
36. Stadler, J., T. R. Billiar, R. D. Curran, D. J. Stuehr, J. B. Ochoa, and R. L. Simmons. 1991. Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes. Am. J. Physiol. 260: C910-C916.
37. Salzman, A. L., M. J. Menconi, N. Unno, R. M. Ezzel, D. M. Casey, P. K. Gonzalez, and M. P. Fink. 1995. Nitric oxide dilates tight junctions and deletes ATP in cultured Caco-2BBe intestinal epithelial monolayers. Am. J. Physiol. 268:G361-G373.
38. Stadler, J., D. Barton, H. Beil-Moeller, S. Diekmann, C. Hierholzer, W. Erhard, and C. D. Heidecke. 1995. Hepatocyte nitric oxide biosynthesis inhibits glucose output and competes with urea synthesis for L-argiaine. Am. J. Physiol. 268:G183-G188.
39. Horton, R. A., R. G. Knowles, and M. A. Titheradge. 1994. Endotoxin causes reciprocal changes in hepatic nitric oxide synthesis, gluconeogenesis, and flux through phosphoenolpyruvate carboxykinase. Biochem. Biophys. Res. Commun. 204:659-665.
40. Brass, E. P., and W. H. Vetter. 1993. Inhibition of glucagon-stimulated glycogenolysis by S-nitroso-N-acetylpenicillamine. Pharmacol. Toxicol. 72:369-372.
41. Albina, J. E., and B. Mastrofrancesco. 1993. Modulation of glucose metabolism in macrophages by products of nitric oxide synthase. Am. J. Physiol. 264:C1594-C1599.
42. Cobb, J. P., C. Natanson, Z. M. N. Quezado, W. D. Hoffman, C. A. Koev, S. Banks, R. Correa, R. Levi, R. J. Elin, J. M. Hosseini, and R. L. Danner. 1995. Differential hemodynamic effects of L-NMMA in endotoxemic and normal dogs. Am. J. Physiol. 268:H1634-H1642.
43. Minnard, E. A., J. Shou, H. Naama, A, Cech, H. Gallagher, and J. M. Daly. 1994. Inhibition of nitric oxide synthesis is detrimental during endotoxemia. Arch. Surg. 129:142-148.